Publisert 17.06.2020

AquaHeal 3D update (EU funded project)

Regenics updates on the 17.3 mill NOK coordination of EU BlueBio Cofund R&D project. RISE (Swe) and Charles River (US) partners

Regenics reported progress in the R&D project funded by Norwegian Reserch Council and the EU commision (25%) on June 9th 2020. The project has reached an early prototype stage as is shown by the slide below and making good progress. 

The US, EPO and RoW patented bioactive HTX ("Heat treated X") is integrated into a 3D printed wound patch using only marine derived ingredients.  A total of 19 European projects were selected for funding and Regenics AS was the only non academic partner to coordinate one of the consortia.

Funding for the coordinator Regenics AS is provided  by the Research Council of Norway, while FORMAS (Swe) and Innovationsfonden (Dk) are the funding bodies of the Swedish and Danish partners, RISE Institute (Swe) and Charles Rivers Lab (US, Dk).

 For more info, please contact Karin Gilljam at kg@regenics.no or mobile +47 91809887

 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.